Citadel Advisors’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Citadel Advisors’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-685,980	Closed	-$6.78M	–	15883
2022 Q3	$6.78M	Buy	685,980 +16,647	+2%	+$164K	﹤0.01%	3372
2022 Q2	$6.57M	Buy	669,333 +3,963	+0.6%	+$38.8K	﹤0.01%	3318
2022 Q1	$6.53M	Buy	665,370 +613	+0.1%	+$5.98K	﹤0.01%	3670
2021 Q4	$6.48M	Sell	664,757 -501,151	-43%	-$4.9M	﹤0.01%	3849
2021 Q3	$11.3M	Buy	1,165,908 +561,748	+93%	+$5.45M	﹤0.01%	2858
2021 Q2	$5.85M	Buy	604,160 +1,080	+0.2%	+$10.6K	﹤0.01%	4104
2021 Q1	$5.8M	Buy	+603,080	New	+$5.89M	﹤0.01%	3943

Citadel Advisors's SSAA Position: Q4 2022 in Review

Citadel Advisors sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 685,980 shares — an estimated $6.78M sold.

Citadel Advisors first reported a position in SSAA in Q1 2021 and held it in 7 quarters. The position peaked at $11.3M in Q3 2021. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Citadel Advisors reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 685,980 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $6.78M.
Citadel Advisors first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2021 and held it in 7 quarters.
Citadel Advisors's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $11.3M in Q3 2021.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.